2013 Law Enforcement Track

Download a 29-page Preview Guide (pdf) to the 2013 National Rx Drug Abuse Summit.

Health Care Investigations
Tuesday, April 2, 2013, 12:30 pm – 1:45 pm
 Moderator David J. Ward, JD
Shareholder and Attorney, Litigation Section, Chambliss, Bahner & Stophel
 Presenters Agent Bruce DiVincenzo
Delaware State Police Drug Diversion Unit
Karen Matthew
Director of Investigations and Inspections, North Carolina Department of Pharmacy
 Session Description According to the Centers for Disease Control and Prevention (CDC), more than 475,000 Emergency Room visits per year are attributed to the misuse of prescription drugs. The CDC also notes that enough prescription painkillers were prescribed in 2010 to medicate every American adult around-the-clock for one month. With the number of prescriptions available and the demand for painkillers increasing, there is great risk of the drugs being misused or abused among patients and health care providers.

In this session, attendees will discover best practices to investigate diversion within a health care facility. In addition, we’ll also discuss how law enforcement can best collaborate with pharmacists to prevent diversion in the pharmacy and the community. Finally, attendees will hear how the Prescription Drug Monitoring Program (PDMP) can be best utilized in diversion cases.

 Learning Objectives 1. List signs of diversion in a health care facility.
2. Outline how to collaborate with clinicians to prevent diversion.
3. Demonstrate effective use of the PDMP by law enforcement within a pharmacy.
Building Public Safety and Public Health Partnerships to Reduce Prescription Drug Abuse
Tuesday, April 2, 2013, 2:00 pm – 3:15 pm
 Moderator Hon. Tom Handy
Commonwealth Attorney (ret.), Kentucky 27th Judicial Circuit, and Board Member, Operation UNITE
 Presenters Laurence Busching
First Deputy Criminal Justice Coordinator, City of New York
Edward Carrasco
Deputy Inspector, Commanding Officer, Special Projects, Office of Management Analysis and Planning, New York Police Department
Dr. Jessica Kattan, MD, MPH
CDC Health Systems Integration Program Scholar, SciMetrika Contractor, Bureau of Alcohol and Drug Use Prevention, Care and Treatment, New York City Department of Health and Mental Hygiene
Denise Paone
Director of Research and Surveillance, Bureau of Alcohol and Drug Use Prevention, Care and Treatment, New York City Department of Health and Mental Hygiene
Chauncey Parker
Director, New York/New Jersey HIDTA
 Session Description According to the Centers for Disease Control and Prevention (CDC), 100 people die from drug overdoses every day in America. Prescription drug abuse is a national public health burden that requires collaboration among all involved parties. The CDC also notes that prescription drug abuse is the fastest growing drug problem in the country.

In this session, attendees will learn how to use public health data to create a plan for law enforcement, treatment, and educators to collaboratively approach this growing epidemic. The New York/New Jersey High-Intensity Drug Trafficking Area (HIDTA) has initiated many projects that have created alliances across agency lines to enhance coordination and information sharing among law enforcement agencies. These alliances have created the following initiatives: the Investigative Support Center, the computerization of law enforcement intelligence reports and arrest photographs (PIMs), the Urban Training Center, the Citywide Armory Project, among others that have particularly benefited law enforcement agencies in the region.

 Learning Objectives 1. Outline strategies to create alliances across agency lines.
2. Explain how to leverage public health data in investigations.
3. Outline the importance of collaboration between public health officials and law enforcement in investigations.
Strategies for Successful Pharmaceutical Drug Diversion Investigations
Tuesday, April 2, 2013, 3:30 pm – 4:45 pm
 Moderator Dan Smoot
Vice President, Operation UNITE
 Presenter Joseph T. Rannazzisi
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration (DEA)
 Session Description According to the 2010 National Drug Threat Assessment, between 2007 and 2009 the rate of diversion of prescription painkillers more than doubled, with opioid pain relievers being the most commonly diverted drug. Pharmaceutical drug diversion investigations can be some of the most complicated and challenging cases for investigators. Successful cases require close coordination between law enforcement agencies at the local, state, and federal levels, as well as close coordination with various regulatory boards.

Participants in this session will learn investigative strategies from case studies of successful prescription drug diversion investigations, focusing on strategies that target rogue doctors, pharmacies, and clinic owners. Attendees will receive information regarding criminal and/or civil actions.

Note: This session will be open only to current law enforcement officers and prosecutors to protect the integrity of ongoing cases. Officers must show identification in order to gain access to this session.

 Learning Objectives 1. Examine reasons for the increasing rate of diversion and abuse of prescription painkillers.
2. Evaluate effective strategies for drug diversion investigations.
3. Describe opportunities for law enforcement agencies to collaborate with regulatory agencies during drug diversion investigations.
Two Unique Approaches
Wednesday, April 3, 2013, 1:30 pm – 2:45 pm
 Moderator Jackie L. Steele, Jr., JD
Commonwealth Attorney, Kentucky 27th Judicial Circuit, and Board Member, Operation UNITE
 Presenters Dr. Gary R. Martin
Homicide Detective, Palm Beach County (FL) Sheriff’s Office
Jason Parman
Assistant U.S. Attorney, London, KY
 Session Description According to the FBI, Rx drug abuse remains as the highest crime category for drug arrests. Out of more than 1.5 million arrests for drug offenses in 2011, 315,000 of these arrests were due to Rx Drug Abuse. This represents more than 860 arrests daily for Rx drug-related charges alone. In this session, participants will hear two unique approaches to securing arrests for Rx drug abuse violations.

One approach utilizes a community-based model for combating drug overdose deaths which employ collaboration between community groups and law enforcement. The discussion provides participants with a description of the various prevention and intervention strategies that make up the Palm Beach County Sheriff’s Office.

The second approach is securing federal homicide charges for drug trafficking. Based on an overdose death in London, KY, a drug dealer surrendered a guilty plea and was sentenced to 327 months incarceration. Review of this case will highlight the substantial punitive impact of the prosecution compared to oxycodone distribution conspiracies that involve substantially greater quantities of controlled substances.

These case studies will outline how to build partnerships between various state and federal agencies can work to produce effective outcomes.

 Learning Objectives 1. Outline investigative priorities in building an overdose death prosecution.
2. State the benefit of building strategic cooperation between federal and state law enforcement agencies.
3. Demonstrate how law enforcement can work together with community prevention programs in investigations.
Undercover Investigations
Wednesday, April 3, 2013, 3:00 pm – 4:15 pm
 Moderator Tony Loya
Director, National Methamphetamine and Pharmaceuticals Initiative

 Presenters James Deater
Law Enforcement Education Coordinator, Atlantic Region, American Military University
Brian Elliott
Detective, Frederick County (MD) Sheriff’s Office
 Session Description According to a CNN Report, prices for prescription painkillers sold illegally are creating a fast-growing street market for prescription painkillers. The street price for OxyContin is $50 to $80 per pill, while Oxycodone sells for $12 to $40 per pill. In a pharmacy, both pills sell for $6. With more than 54,000 assaults on police officers in 2011, the demand for these drugs is fostering a dangerous environment for officers and prompting the need for alternative methods of investigation.

In this session, attendees will hear examples of building successful prosecutions while maintaining officer safety during undercover investigations. Methods that are being employed by Rx pill dealers in attempts to evade arrest and prosecution will also be discussed. Best practices will be outlined so attendees can apply them in their respective jurisdictions to build cases while maintaining officer safety.

Note: This session will be open only to current law enforcement officers and prosecutors to protect the integrity of ongoing cases. Officers must show identification in order to gain access to this session.

 Learning Objectives 1. Describe methods Rx drug dealers and “pill-mill doctors” are using to evade prosecution.
2. Identify safety concerns for officers dealing with Rx drug dealers.
3. Plan undercover strategies that you can implement in your jurisdictions.